SBIR-STTR Award

Development of Novel Gold Binding Fusion Proteins
Award last edited on: 7/9/07

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$896,288
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Meher Irani

Company Information

BioHesion Inc (AKA: Protein Systems)

1208 NE 100th Street
Seattle, WA 98125
   (206) 235-3435
   info@biohesion.com
   www.biohesion.com
Location: Single
Congr. District: 07
County: King

Phase I

Contract Number: 1R43CA101579-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2003
Phase I Amount
$96,359
The ability to directly and uniformly immobilize proteins onto detection surfaces in a robust and simple way, with full retention of biological activity is a highly coveted goal in the field of bioengineering. It leads to the development of high value devices and applications which will have a tremendous impact on basic research, drug discovery, diagnostics and biodetection. An excellent way to achieve this is to use the property of known gold binding peptides to strongly adhere to gold surfaces under very mild binding conditions and to covalently attach any desired target protein to such peptides by recombinant means. The specific aims of this proposal are: a) to test the feasibility of producing gold binding peptides in Escherichia coli as fusion proteins with molecules of biological and commercial relevance such as protein A and streptavidin; b) to optimize the expression and purification conditions; c) to characterize and optimize gold binding of the fusion proteins; d) to construct and characterize biosensors with these recombinant fusion proteins. The long-term aim of this project is to expand the expression capabilities to a host of other molecules of biological and commercial significance and develop biosensing devices and assays for a wide variety of applications of considerable commercial potential.

Thesaurus Terms:
chimeric protein, gold, protein binding, protein engineering, transfection Escherichia coli, binding protein, biosensor, biotin, transfection /expression vector biotechnology, protein purification

Phase II

Contract Number: 2R44CA101579-02A2
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2005
(last award dollars: 2006)
Phase II Amount
$799,929

The ability to directly and uniformly immobilize proteins onto surfaces in robust fashion with full retention of activity is a highly coveted goal in the fields of biodetection and bioengineering. More efficient attachment methods suitable for a wide range of polypeptides will lead to the development of high-value applications, devices and systems that will significantly impact research, drug discovery, diagnostics, biodetection, and biomimetics. The proposed goal of controlling molecular orientation during protein immobilization on inorganic surfaces is essential to emerging applications of biomimetics including biomineralization and nano-architecture. In this project, we achieve our objective through the development of fusion proteins with gold-binding peptides that confer high-affinity gold binding under mild conditions. In phase I we chose Protein A and Streptavidin as fusion partners because they have established commercial value in numerous applications. Compared to conventional procedures to immobilize polypeptides to gold, e.g., adsorption and chemical methods, our affinity tag for gold approach provides greater stability, reduced interference, and high specific activity of fusion partners, all of which contribute to higher sensitivity of biodetection. We achieved proof of concept in phase I and propose to complete the characterization and optimization of gold-binding of our fusion proteins with the goal of developing a high-affinity tag for immobilizing virtually any polypeptide on gold. In addition, we propose to develop prototype surface plasmon resonance biosensors using our fusion proteins for several commercial applications. Also, we propose to produce specific mutant forms of the gold-binding peptide to better understand the structure/activity relationship of gold binding with the goal of designing more efficient affinity tags for specialized applications using unique gold substrates, e.g., nanogold particles. Successful completion of phase II studies will produce high-value reagents and prototype sensor applications with strong commercial potential and significant societal benefits. In the long term, achieving our goals will significantly impact the areas of surface chemistry, biodetection, and biomaterials